Sitafloxacin- Versus Moxifloxacin-Based Sequential Treatment for Mycoplasma Genitalium Infections: Protocol for a Multicenter, Open-Label Randomized Controlled Trial.
JMIR Res Protoc
; 12: e52565, 2023 Nov 14.
Article
in En
| MEDLINE
| ID: mdl-37962941
Mycoplasma genitalium; RCT; STD; STI; bacteria; bacterial; clinical trial; clinical trials; controlled trials; doxycycline; drug; drugs; genital; genitalia; infection; medication; medications; moxifloxacin; pharmaceutic; pharmaceutical; pharmaceuticals; pharmaceutics; pharmacology; pharmacotherapy; pharmacy; quinolone resistance-associated mutation; randomized controlled trial; sexual transmission; sexually transmitted; sexually transmitted infection; sitafloxacin
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
JMIR Res Protoc
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: